Activated protein C reduces tissue hypoxia, inflammation, and apoptosis in traumatized skeletal muscle during endotoxemia. 2007

Philip Gierer, and Johannes N Hoffmann, and Felix Mahr, and Michael D Menger, and Thomas Mittlmeier, and Georg Gradl, and Brigitte Vollmar
Institute for Experimental Surgery, University of Rostock, Germany.

OBJECTIVE Extensive surgical trauma leads to activation of the coagulation cascade and is often complicated by systemic inflammation and infection. Activated protein C, a natural coagulatory inhibitor, was recently shown to reduce mortality in septic patients. We herein report on the actions of activated protein C on skeletal muscle injury in experimental endotoxemia. METHODS Prospective controlled animal study. METHODS University animal research facility. METHODS Male Sprague-Dawley rats. METHODS Closed soft tissue trauma was applied on the left hind limb of pentobarbital-anesthetized rats. Six hours later endotoxemia was induced by intraperitoneal injection of Escherichia coli lipopolysaccharide. An equivalent volume of physiologic saline was given in controls. At the same time point, treatment of animals was started by continuous intravenous application of activated protein C (24 microg/kg.hr) or vehicle solution over 18 hrs. Twenty-four hours after trauma, the extensor digitorum longus muscle was microsurgically exposed and analyzed by means of high-resolution multifluorescence microscopy. RESULTS Endotoxemia aggravated traumatized muscle injury, as evidenced by reduced nutritive perfusion, increased tissue hypoxia, enhanced leukocyte-endothelial cell interaction, and apoptotic myocyte cells (249 +/- 17 cm/cm vs. 298 +/- 22 cm/cm; reduced nicotinamide adenine dinucleotide [NADH], 149 +/- 15 arbitrary units [AU] vs. 130 +/- 13 AU; 417 +/- 79 cells/mm vs. 344 +/- 77 cells/mm and 62 +/- 9 cells/mm vs. 31 +/- 5 cells/mm). Therapeutic intervention with activated protein C 6 hrs after trama protected nutritive perfusion and tissue oxygenation (341 +/- 24 cm/cm and 115 +/- 8 AU) and reduced inflammatory leukocyte adherence (185 +/- 60 cells/mm) and cellular apoptosis (15 +/- 4 cells/mm). Of note, the protection of traumatized muscle tissue by activated protein C was also maintained during endotoxemia, as indicated by a functional capillary density of 379 +/- 10 cm/cm, a NADH-fluorescence of 102 +/- 6 AU, a leukocyte adherence of 82 +/- 12 cells/mm, and a myocyte apoptosis of 28 +/- 4 cells/mm. CONCLUSIONS Microcirculatory injury of traumatized skeletal muscle tissue is enhanced by intravenous endotoxin application in this model of soft tissue trauma. Activated protein C ameliorates microcirculatory dysfunction and tissue injury, in particular in traumatized animals during endotoxemia.

UI MeSH Term Description Entries
D007249 Inflammation A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function. Innate Inflammatory Response,Inflammations,Inflammatory Response, Innate,Innate Inflammatory Responses
D008070 Lipopolysaccharides Lipid-containing polysaccharides which are endotoxins and important group-specific antigens. They are often derived from the cell wall of gram-negative bacteria and induce immunoglobulin secretion. The lipopolysaccharide molecule consists of three parts: LIPID A, core polysaccharide, and O-specific chains (O ANTIGENS). When derived from Escherichia coli, lipopolysaccharides serve as polyclonal B-cell mitogens commonly used in laboratory immunology. (From Dorland, 28th ed) Lipopolysaccharide,Lipoglycans
D008297 Male Males
D008833 Microcirculation The circulation of the BLOOD through the MICROVASCULAR NETWORK. Microvascular Blood Flow,Microvascular Circulation,Blood Flow, Microvascular,Circulation, Microvascular,Flow, Microvascular Blood,Microvascular Blood Flows,Microvascular Circulations
D009102 Multiple Organ Failure A progressive condition usually characterized by combined failure of several organs such as the lungs, liver, kidney, along with some clotting mechanisms, usually postinjury or postoperative. MODS,Multiple Organ Dysfunction Syndrome,Organ Dysfunction Syndrome, Multiple,Organ Failure, Multiple,Failure, Multiple Organ,Multiple Organ Failures
D011486 Protein C A vitamin-K dependent zymogen present in the blood, which, upon activation by thrombin and thrombomodulin exerts anticoagulant properties by inactivating factors Va and VIIIa at the rate-limiting steps of thrombin formation.
D000704 Analysis of Variance A statistical technique that isolates and assesses the contributions of categorical independent variables to variation in the mean of a continuous dependent variable. ANOVA,Analysis, Variance,Variance Analysis,Analyses, Variance,Variance Analyses
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000925 Anticoagulants Agents that prevent BLOOD CLOTTING. Anticoagulant Agent,Anticoagulant Drug,Anticoagulant,Anticoagulant Agents,Anticoagulant Drugs,Anticoagulation Agents,Indirect Thrombin Inhibitors,Agent, Anticoagulant,Agents, Anticoagulant,Agents, Anticoagulation,Drug, Anticoagulant,Drugs, Anticoagulant,Inhibitors, Indirect Thrombin,Thrombin Inhibitors, Indirect
D017207 Rats, Sprague-Dawley A strain of albino rat used widely for experimental purposes because of its calmness and ease of handling. It was developed by the Sprague-Dawley Animal Company. Holtzman Rat,Rats, Holtzman,Sprague-Dawley Rat,Rats, Sprague Dawley,Holtzman Rats,Rat, Holtzman,Rat, Sprague-Dawley,Sprague Dawley Rat,Sprague Dawley Rats,Sprague-Dawley Rats

Related Publications

Philip Gierer, and Johannes N Hoffmann, and Felix Mahr, and Michael D Menger, and Thomas Mittlmeier, and Georg Gradl, and Brigitte Vollmar
November 2002, American journal of physiology. Endocrinology and metabolism,
Philip Gierer, and Johannes N Hoffmann, and Felix Mahr, and Michael D Menger, and Thomas Mittlmeier, and Georg Gradl, and Brigitte Vollmar
August 2022, Cells,
Philip Gierer, and Johannes N Hoffmann, and Felix Mahr, and Michael D Menger, and Thomas Mittlmeier, and Georg Gradl, and Brigitte Vollmar
September 2017, Journal of cellular biochemistry,
Philip Gierer, and Johannes N Hoffmann, and Felix Mahr, and Michael D Menger, and Thomas Mittlmeier, and Georg Gradl, and Brigitte Vollmar
August 2007, Molecular and cellular biochemistry,
Philip Gierer, and Johannes N Hoffmann, and Felix Mahr, and Michael D Menger, and Thomas Mittlmeier, and Georg Gradl, and Brigitte Vollmar
April 2004, Critical care medicine,
Philip Gierer, and Johannes N Hoffmann, and Felix Mahr, and Michael D Menger, and Thomas Mittlmeier, and Georg Gradl, and Brigitte Vollmar
June 2006, Intensive care medicine,
Philip Gierer, and Johannes N Hoffmann, and Felix Mahr, and Michael D Menger, and Thomas Mittlmeier, and Georg Gradl, and Brigitte Vollmar
December 2008, Journal of orthopaedic research : official publication of the Orthopaedic Research Society,
Philip Gierer, and Johannes N Hoffmann, and Felix Mahr, and Michael D Menger, and Thomas Mittlmeier, and Georg Gradl, and Brigitte Vollmar
March 2008, Shock (Augusta, Ga.),
Philip Gierer, and Johannes N Hoffmann, and Felix Mahr, and Michael D Menger, and Thomas Mittlmeier, and Georg Gradl, and Brigitte Vollmar
November 2005, Journal of orthopaedic research : official publication of the Orthopaedic Research Society,
Philip Gierer, and Johannes N Hoffmann, and Felix Mahr, and Michael D Menger, and Thomas Mittlmeier, and Georg Gradl, and Brigitte Vollmar
June 2019, Haematologica,
Copied contents to your clipboard!